comparemela.com

Latest Breaking News On - State drug controllers - Page 6 : comparemela.com

Centre caps trade margin on oxygen concentrators 70% to curb black-marketing, high prices

Centre caps trade margin on oxygen concentrators 70% to curb black-marketing, high prices NPPA has instructed manufacturers to report revised MRP in 3 days, and revised rates will be made public in a week. Every retailer, dealer, hospital and institution will display a price list as furnished by manufacturer in a manner so it s easily accessible to any person wishing to consult it BusinessToday.In | June 4, 2021 | Updated 20:45 IST SDCs will monitor compliance to ensure no manufacturer, distributor, retailer sells oxygen concentrators at a price exceeding revised MRP The government has capped the trade margin on oxygen concentrators at 70 per cent from up to 198 per cent being charged currently, in view of increasing black-marketing cases and volatility in their maximum retail prices (MRP). The order will be applicable up to November 30, 2021, subject to review.

National-pharmaceutical-pricing-authority
Central-drugs-standard-control-organisation
Trade-margin
Prices-control
State-drug-controllers
Oxygen-concentrators
Oxygen-concentrators-margin-capped
Black-marketing-cases
Mrp-of-oxygen-concentrators
Chemicals-and-fertilisers
Oxygen-manufacturers

Covid update: Daily new cases continue to plateau in 12 States

Covid update: Daily new cases continue to plateau in 12 States May 06, 2021 × No loosening grip, single day’s laxity may squander efforts made till now, cautions Health Ministry official There is a continued plateauing in daily new Covid 19 cases in as many as a dozen States over the last two weeks, but it not time to loosen the grip as it could cost the country hugely in the near future, a Health Ministry official said on Wednesday. These States and Union Territories witnessing a declining trend in daily cases are Maharashtra, Uttar Pradesh, Delhi, Chhattisgarh, Gujarat, Madhya Pradesh, Telangana, Jharkhand, Daman & Diu, Ladakh, Lakshadweep and Andaman & Nicobar.

India
Jammu
Jammu-and-kashmir
Ladakh
Uttarakhand
Uttaranchal
Karnataka
Lakshadweep
Uttar-pradesh
Delhi
Kerala
Bihar

16.5 lakh vials of Remdesivir allocated to states between May 3-May 9: Centre

16.5 lakh vials of Remdesivir allocated to states between May 3-May 9: Centre ANI | Updated: May 05, 2021 17:10 IST New Delhi [India], May 5 (ANI): The Centre on Wednesday informed that 16.5 lakh vials of Remdesivir were allocated to states between May 3 and May 9 , in wake of the Covid-19 pandemic. Union Minister of Chemicals and Fertilisers, DV Sadananda Gowda chaired a meeting to review the availability of drugs for Covid treatment and other essential drugs , informed an official release by the Ministry of Chemicals and Fertilizers. Gowda during the meeting appreciated the efforts of all seven manufacturers of Remdesivir for increasing the production capacity to 1.03 crore vials per month, up from 38 lakh vials per month a month ago. This increased capacity will augment the domestic availability of the injection.

India
New-delhi
Delhi
Dv-sadananda-gowda
Centre-on
Department-of-pharma
National-pharmaceutical-pricing-authority
Ministry-of-health
Drug-administration
Ministry-of-chemicals
Central-drugs-standard-control-organisation
Drugs-controller-general

Daily new cases continue to plateau in 12 States: Health Ministry

Daily new cases continue to plateau in 12 States: Health Ministry May 05, 2021 Inter-ministerial panel looking at deployment of aid received from foreign countries, says official There continues to be a plateauing in daily Covid-19 cases in 12 States in the last 14 days, Health Ministry data showed. These States are Maharashtra, Uttar Pradesh, Delhi, Chhattisgarh, Gujarat, Madhya Pradesh, Telangana, Jharkhand, Daman & Diu, Ladakh, Lakshadweep and Andaman & Nikobar. However, Health Ministry official Lav Agarwal said this is not the time to loosen up seeing the early decline as it may cost dearly to the country, going forward. “In the case of infections, even a single day laxity may squander the efforts made to come to a low level of Coronavirus cases. That’s why there is a need to make continuous efforts towards containing the further spread,” said Agarwal, who is a Joint Secretary in the Health Ministry.

India
Jammu
Jammu-and-kashmir
Ladakh
Uttarakhand
Uttaranchal
Karnataka
Lakshadweep
Uttar-pradesh
Delhi
Kerala
Bihar

Black marketing of Covid-19 drugs condemnable attempt to exploit peoples' misery: SC | India News

NEW DELHI: Black marketing of critical Covid-19 drugs and oxygen is a condemnable attempt to exploit peoples misery, the Supreme Court has said, directing the Centre to consider constituting a special team to identify and prosecute offenders. The apex court also said that a protocol must be evolved for ambulances to avoid extraction of unconscionable charges from citizens and the Centre can consider creating a platform for easy reporting and redressal of such cases. A bench headed by Justice D Y Chandrachud noted that several critical drugs such as Remdesivir and Tocilizumab, are being sold at significantly inflated prices or in fake form.

L-nageswara-rao
Justicedy-chandrachud
Supreme-court
Central-drugs-standard-control-organisation
Central-government
Justicesl-nageswara-rao
State-drug-controllers
India
Ndia-news
Ndia-news-today
Oday-news
Google-news

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.